PURE Bioscience, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
PURE Bioscience, Inc. (PURE) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $13.10 million for the 12-month period ending 2018-07-31, per its 10-K filed 2018-10-25.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2018-10-25
- PURE Bioscience, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2018 was $13.10M, a 1517.65% increase from fiscal 2017.
- PURE Bioscience, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was $810.00K, a 66.57% decline from fiscal 2016.
- PURE Bioscience, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2016 was $2.42M, a 21.20% decline from fiscal 2015.
- PURE Bioscience, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2015 was $3.08M, a 1.47% decline from fiscal 2014.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2018-07-31 | $13.10M 10-K · filed 2018-10-25 | |
| 2017-07-31 | $810.00K 10-K · filed 2017-10-26 | |
| 2016-07-31 | $2.42M 10-K · filed 2017-10-26 | |
| 2015-07-31 | $3.08M 10-K · filed 2016-10-27 | $3.80M 10-K · filed 2015-10-28 |
| 2014-07-31 | $3.12M 10-K · filed 2014-10-28 | |
| 2013-07-31 | $2.09M 10-K · filed 2013-10-24 | |
| 2012-07-31 | $2.66M 10-K · filed 2012-10-29 |